1. Asia-Pacific Diabetes Care Devices Market Outlook to 2018 -
Glucose Monitoring and Insulin Delivery
Report Details:
Published:September 2012
No. of Pages: 95
Price: Single User License – US$3500
Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin
Delivery
Summary
GlobalData’s new report, “Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose
Monitoring and Insulin Delivery” provides key market data on the Asia-Pacific Diabetes Care
Devices market – Australia, China, India and Japan. The report provides value (USD million) data
for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides
company shares and distribution shares data for each of the aforementioned market categories.
The report is supplemented with global corporate-level profiles of the key market participants.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Countries covered include Australia, China, India and Japan.
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) data for each of the market categories in each of the
country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and
countries.
- Global corporate-level profiles of key companies operating within the Asia-Pacific Diabetes Care
Devices market..
- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Novo Nordisk A/S,
Arkray, Inc., Eli Lilly and Company, Abbott Laboratories and others.

2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Asia-Pacific Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/197474-asia-pacific-diabetes-care-devices-market-outlook-to-2018-
glucose-monitoring-and-insulin-delivery.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Diabetes Care Devices in Asia-Pacific 10
3.1 Diabetes Care Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018
10
3.2 Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018 11
3.3 Diabetes Care Devices, Asia-Pacific, Company share (2010-2011) 16
4 Diabetes Care Devices In Japan 18
4.1 Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018 18
4.2 Diabetes Care Devices, Japan, Distribution Share (2010-2011) 23
4.2.1 Glucose Monitoring, Japan, Distribution Share (2010-2011) 23
4.2.2 Insulin Delivery, Japan, Distribution Share (2010-2011) 23
4.3 Diabetes Care Devices, Japan, Company Share (2010-2011) 24
4.3.1 Diabetes Care Devices, Japan, Company Share (2010-2011) 24
4.3.2 Glucose Monitoring, Japan, Company Share (2010-2011) 26
4.3.3 Insulin Delivery, Japan, Company Share (2010-2011) 28
5 Diabetes Care Devices In Australia 30
5.1 Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 30
5.2 Diabetes Care Devices, Australia, Distribution Share (2010-2011) 35
5.2.1 Glucose Monitoring, Australia, Distribution Share (2010-2011) 35
5.2.2 Insulin Delivery, Australia, Distribution Share (2010-2011) 35
5.3 Diabetes Care Devices, Australia, Company Share (2010-2011) 36

3. 5.3.1 Diabetes Care Devices, Australia, Company Share (2010-2011) 36
5.3.2 Glucose Monitoring, Australia, Company Share (2010-2011) 38
5.3.3 Insulin Delivery, Australia, Company Share (2010-2011) 40
6 Diabetes Care Devices In China 42
6.1 Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 42
6.2 Diabetes Care Devices, China, Distribution Share (2010-2011) 47
6.2.1 Glucose Monitoring, China, Distribution Share (2010-2011) 47
6.2.2 Insulin Delivery, China, Distribution Share (2010-2011) 47
6.3 Diabetes Care Devices, China, Company Share (2010-2011) 48
6.3.1 Diabetes Care Devices, China, Company Share (2010-2011) 48
6.3.2 Glucose Monitoring, China, Company Share (2010-2011) 50
6.3.3 Insulin Delivery, China, Company Share (2010-2011) 52
7 Diabetes Care Devices In India 54
7.1 Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 54
7.2 Diabetes Care Devices, India, Distribution Share (2010-2011) 59
7.2.1 Glucose Monitoring, India, Distribution Share (2010-2011) 59
7.2.2 Insulin Delivery, India, Distribution Share (2010-2011) 59
7.3 Diabetes Care Devices, India, Company Share (2010-2011) 60
7.3.1 Diabetes Care Devices, India, Company Share (2010-2011) 60
7.3.2 Glucose Monitoring, India, Company Share (2010-2011) 62
7.3.3 Insulin Delivery, India, Company Share (2010-2011) 64
8 Overview of Key Companies in Asia-Pacific Diabetes Care Devices Market 66
8.1 F. Hoffmann-La Roche Ltd. 66
8.1.1 Company Overview 66
8.1.2 Share in the Asia-Pacific Diabetes Care Devices Market 66
8.2 LifeScan, Inc. 67
8.2.1 Company Overview 67
8.2.2 Share in the Asia-Pacific Diabetes Care Devices Market 67
8.3 Novo Nordisk A/S 68
8.3.1 Company Overview 68
8.3.2 Share in the Asia-Pacific Diabetes Care Devices Market 68
8.4 ARKRAY, Inc. 69
8.4.1 Company Overview 69
8.4.2 Share in the Asia-Pacific Diabetes Care Devices Market 69
8.5 Eli Lilly and Company 70
8.5.1 Company Overview 70
8.5.2 Share in the Asia-Pacific Diabetes Care Devices Market 70
8.6 Abbott Laboratories 71
8.6.1 Company Overview 71
8.6.2 Share in the Asia-Pacific Diabetes Care Devices Market 71
8.7 Sanofi 72
8.7.1 Company Overview 72

4. 8.8 Medtronic, Inc. 72
8.8.1 Company Overview 72
8.9 Bayer HealthCare AG 73
8.9.1 Company Overview 73
8.10 Terumo Corporation 73
8.10.1 Company Overview 73
8.11 Becton, Dickinson and Company 74
8.11.1 Company Overview 74
8.12 Nipro Corporation 74
8.12.1 Company Overview 74
8.13 Hindustan Syringes & Medical Devices Ltd. 75
8.13.1 Company Overview 75
8.14 Animas Corporation 75
8.14.1 Company Overview 75
8.15 B. Braun Melsungen AG 75
8.15.1 Company Overview 75
9 Diabetes Care Devices Market Pipeline Products 76
10 Financial Deals Landscape 79
10.1 Partnerships 79
10.1.1 Bioton And SciGen Amend Distribution Agreement With Bayer HealthCare 79
10.1.2 Insulet Expands Distribution Agreement With Ypsomed Holding 81
11 Recent Developments 82
11.1 Strategy And Business Planning 82
11.1.1 Aug 28, 2012: Medtronic Opens Shanghai Innovation Center 82
11.1.2 Aug 09, 2012: Takeda Establishes Development Center In China 82
11.1.3 Apr 06, 2012: Biocon Opens New INR2 Billion Biologics Research Facility In Bangalore,
India 83
11.1.4 Mar 27, 2012: Terumo Establishes New Holding Company In Singapore 83
11.1.5 Nov 04, 2011: Takeda Announces New Structure Of Business Operations 84
11.2 Research And Development 85
11.2.1 Jul 17, 2012: Greatbatch To Establish R&D Centre In Singapore 85
11.2.2 Apr 04, 2012: Takeda Joins Structural Genomics Consortium To Fund Collective Drug
Research 86
11.2.3 Mar 27, 2012: Bayer HealthCare And Tsinghua University Extend Innovative Drug
Discovery Partnership 87
11.3 Legal and Regulatory 88
11.3.1 Aug 01, 2012: Terumo Files Lawsuit For Compensation Of Damages Against Olympus 88
11.3.2 Jun 29, 2012: Sucampo Pharma Provides Update On Anticipated Arbitration Decision 88
11.3.3 May 30, 2012: Sucampo Announces Change In Date Of Anticipated Arbitration Decision In
Dispute With Takeda 88
11.3.4 Apr 17, 2012: Sanmina-SCI Suzhou, China Facility Receives ISO 13485 Certification For
Medical Devices 89

5. 12 Appendix 90
12.1 Definitions of Markets Covered in the Report 91
12.1.1 Diabetes Care Devices 91
12.2 Research Methodology 92
12.3 Secondary Research 92
12.4 Primary Research 93
12.5 Models 93
12.6 Forecasts 94
12.7 Expert Panels 94
12.8 GlobalData Consulting 94
12.9 Currency Conversion 95
12.10 Contact Us 95
12.11 Disclaimer 95
1.1 List of Tables
Table 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-
2018 10
Table 2: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018
11
Table 3: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Historic,
2004-2011 13
Table 4: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Forecast,
2011-2018 15
Table 5: Diabetes Care Devices, Asia-Pacific, Company share by Revenue ($m), USD Constant,
2010-2011 17
Table 6: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018 18
Table 7: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 20
Table 8: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 22
Table 9: Glucose Monitoring, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 23
Table 10: Insulin Delivery, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011
23
Table 11: Diabetes Care Devices, Japan, Company Share by Revenue ($m), USD Constant,
2010-2011 25
Table 12: Glucose Monitoring, Japan, Company Share by Revenue ($m), USD Constant, 2010-
2011 27
Table 13: Insulin Delivery, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011
29
Table 14: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 30
Table 15: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-

6. 2011 32
Table 16: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Forecast,
2011-2018 34
Table 17: Glucose Monitoring, Australia, Distribution Share by Revenue ($m), USD Constant,
2010-2011 35
Table 18: Insulin Delivery, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 35
Table 19: Diabetes Care Devices, Australia, Company Share, USD Constant, (2010-2011) 37
Table 20: Glucose Monitoring, Australia, Company Share by Revenue ($m), USD Constant, 2010-
2011 39
Table 21: Insulin Delivery, Australia, Company Share by Revenue ($m), USD Constant, 2010-
2011 41
Table 22: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 42
Table 23: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 44
Table 24: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 46
Table 25: Glucose Monitoring, China, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 47
Table 26: Insulin Delivery, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
47
Table 27: Diabetes Care Devices, China, Company Share, USD Constant, (2010-2011) 49
Table 28: Glucose Monitoring, China, Company Share by Revenue ($m), USD Constant, 2010-
2011 51
Table 29: Insulin Delivery, China, Company Share by Revenue ($m), USD Constant, 2010-2011
53
Table 30: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 54
Table 31: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 56
Table 32: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 58
Table 33: Glucose Monitoring, India, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 59
Table 34: Insulin Delivery, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011
59
Table 35: Diabetes Care Devices, India, Company Share, USD Constant, (2010-2011) 61
Table 36: Glucose Monitoring, India, Company Share by Revenue ($m), USD Constant, 2010-
2011 63
Table 37: Insulin Delivery, India, Company Share by Revenue ($m), USD Constant, 2010-2011 65
Table 38: Diabetes Care Devices Market Pipeline Products 76
Table 39: Bioton And SciGen Amend Distribution Agreement With Bayer HealthCare 79
Table 40: Insulet Expands Distribution Agreement With Ypsomed Holding 81

7. 1.2 List of Figures
Figure 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m), USD Constant,
2004-2018 10
Figure 2: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018
11
Figure 3: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Historic,
2004-2011 12
Figure 4: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Forecast,
2011-2018 14
Figure 5: Diabetes Care Devices, Asia-Pacific, Company share (%), 2011 16
Figure 6: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018 18
Figure 7: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 19
Figure 8: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 21
Figure 9: Diabetes Care Devices, Japan, Company Share (%), 2011 24
Figure 10: Glucose Monitoring, Japan, Company Share (%), 2011 26
Figure 11: Insulin Delivery, Japan, Company Share (%), 2011 28
Figure 12: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 30
Figure 13: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Historic,
2004-2011 31
Figure 14: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Constant, Forecast,
2011-2018 33
Figure 15: Diabetes Care Devices, Australia, Company Share (%), 2011 36
Figure 16: Glucose Monitoring, Australia, Company Share (%), 2011 38
Figure 17: Insulin Delivery, Australia, Company Share (%), 2011 40
Figure 18: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 42
Figure 19: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 43
Figure 20: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 45
Figure 21: Diabetes Care Devices, China, Company Share (%), 2011 48
Figure 22: Glucose Monitoring, China, Company Share (%), 2011 50
Figure 23: Insulin Delivery, China, Company Share (%), 2011 52
Figure 24: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 54
Figure 25: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 55
Figure 26: Diabetes Care Devices, India, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 57
Figure 27: Diabetes Care Devices, India, Company Share (%), 2011 60
Figure 28: Glucose Monitoring, India, Company Share (%), 2011 62

8. Figure 29: Insulin Delivery, India, Company Share (%), 2011 64
Figure 30: F. Hoffmann-La Roche Ltd., Company Share (%), Asia-Pacific Diabetes Care Devices
Market, 2011 66
Figure 31: LifeScan, Inc., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011
67
Figure 32: Novo Nordisk A/S, Company Share (%), Asia-Pacific Diabetes Care Devices Market,
2011 68
Figure 33: ARKRAY, Inc., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2011
69
Figure 34: Eli Lilly and Company, Company Share (%), Asia-Pacific Diabetes Care Devices
Market, 2011 70
Figure 35: Abbott Laboratories, Company Share (%), Asia-Pacific Diabetes Care Devices Market,
2011 71
Contact: sales@reportsandreports.com for more information.